This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| American Journal of Kidney Diseases | |
|---|---|
| Title | American Journal of Kidney Diseases |
| Discipline | Nephrology |
| Abbreviation | Am. J. Kidney Dis. |
| Publisher | Elsevier on behalf of the National Kidney Foundation |
| Country | United States |
| History | 1981–present |
| Frequency | Monthly |
| Impact | 6.5 |
American Journal of Kidney Diseases is a peer-reviewed medical journal covering nephrology, renal medicine, and kidney-related research. The journal is published by Elsevier on behalf of the National Kidney Foundation and serves clinicians, researchers, and policymakers in fields spanning clinical nephrology, dialysis, and transplantation. It publishes original research, reviews, clinical guidelines, commentaries, and case reports relevant to kidney disease care in contexts such as hospital systems and public health initiatives.
The journal was established in 1981 amid developments involving institutions such as the National Institutes of Health, the Centers for Disease Control and Prevention, and academic centers like the Mayo Clinic and Johns Hopkins Hospital. Early editorial leadership included clinicians and researchers with affiliations to Harvard Medical School, University of California, San Francisco, and the University of Pennsylvania, reflecting ties to societies such as the American Society of Nephrology and the European Renal Association–European Dialysis and Transplant Association. Over decades the journal intersected with major events in medicine including policy shifts at the U.S. Congress level, technological advances at companies such as Fresenius Medical Care and DaVita Inc., and collaborative efforts with organizations like the World Health Organization and Kidney Disease: Improving Global Outcomes.
The journal covers clinical trials and basic science studies that relate to patient care, drawing submissions from institutions including the University of Oxford, Massachusetts General Hospital, Stanford University School of Medicine, and the University of Toronto. Content areas include dialysis research tied to manufacturers like Baxter International, transplantation studies involving centers such as Cleveland Clinic Foundation, epidemiology linked to cohorts like the Framingham Heart Study, and health services research that engages networks such as the Agency for Healthcare Research and Quality. The journal also publishes guideline discussions referencing the American Heart Association, European Society of Cardiology, and consensus statements with contributors from the International Society of Nephrology.
The journal is indexed in major databases used by researchers at institutions such as the Library of Congress, and is listed in bibliographic services including PubMed, MEDLINE, EMBASE, and Scopus. Citation metrics appear in platforms maintained by entities like Clarivate, Elsevier's Scopus, and bibliometric analyses produced by groups at University College London and Harvard University. Libraries at universities such as Yale University, Columbia University, and University of Michigan provide access through consortia including the HathiTrust and cataloging systems such as the Dewey Decimal Classification for medical serials.
Editorial oversight has combined editorial boards composed of clinicians and scientists from hospitals like Beth Israel Deaconess Medical Center and research institutes such as the Broad Institute. Policy statements reference ethical frameworks promoted by the International Committee of Medical Journal Editors, conflict-of-interest guidelines echoed by the World Medical Association, and reporting standards tied to groups such as CONSORT, PRISMA, and STROBE. Peer review workflows engage reviewers affiliated with centers including Karolinska Institutet, Imperial College London, and the University of Sydney, while production operations coordinate with Elsevier offices and publishing partners used by journals like The Lancet and The New England Journal of Medicine.
The journal's articles have been cited by authors at institutions such as Oxford University Press, in guidelines from the National Institute for Health and Care Excellence, and in reports by agencies like the World Health Organization. High-impact papers have influenced clinical practice at centers such as Mount Sinai Hospital and policy discussions in venues including testimony to the U.S. Senate. Reception in the academic community is reflected in awards and recognition associated with organizations like the American Society of Nephrology and citations tracked by services such as Google Scholar and Clarivate Analytics.
Notable articles have included multicenter trial reports with collaborators from Duke University Medical Center, guideline syntheses involving KDIGO contributors, and epidemiologic analyses referencing cohorts like the Nurses' Health Study and the National Health and Nutrition Examination Survey. Special issues have focused on themes such as chronic kidney disease in populations studied by the Framingham Heart Study, transplantation ethics discussed at meetings like the World Congress of Nephrology, and acute kidney injury sessions tied to conferences of the American Thoracic Society and American College of Cardiology.
The journal follows a subscription model administered by Elsevier while offering open access options analogous to policies used by publishers such as Wiley and Springer Nature. Authors from institutions like University of California system and State University of New York may utilize article processing charge support from funders including the National Institutes of Health and foundations like the Robert Wood Johnson Foundation. Distribution reaches hospital libraries at systems such as Kaiser Permanente and academic consortia including the Association of American Medical Colleges.
Category:Nephrology journals Category:Elsevier academic journals